Tuberculosis trials and consortium services
Active Definitive Contract Awarded Last action
- Contract number
- 75D30121C10170
- Awardee
-
Weill Medical College Of Cornell University UEI YNT8TCJH8FQ8
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $3,225,561
Award facts
- Opportunity
-
- Tuberculosis Trials Consortium Services Pre-Solicitation · 75D30120R67869 · Posted Feb 5, 2020
- Tuberculosis Trials Consortium Services Solicitation · Posted Apr 16, 2020
- Contract value 56% obligated
-
- $3,225,560.78 Current, with exercised options
- $5,770,309.78 Potential, with all options
- Completion date 59% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 22 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Haiti
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$146,896 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $624,698 | |
| Exercise an Option | $576,919 | |
| Exercise an Option | $566,809 | |
| Exercise an Option | $551,580 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $559,290 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $493,161 |
Show all 12
About this award
The CDC Pittsburgh awarded a $5.77 million definitive contract to Weill Medical College of Cornell University for tuberculosis trials and consortium services on January 1, 2021, with no set-aside, under cost-no-fee pricing through December 31, 2030.
The originating solicitation, posted February 5, 2020, sought clinical research support for tuberculosis trials and studies spanning ten years. Work includes participation in clinical research studies, adherence to study start-up procedures, and involvement as a member site in the Tuberculosis Trials Consortium. The government estimates initiating up to four new studies between the base year and ninth option year, with continuing enrollment, treatment, testing, and follow-up for multiple tuberculosis protocols.
Place of performance is Haiti. Les Centres Gheskio serves as the primary subcontractor, conducting participant recruitment, enrollment, data collection, and follow-up for all tuberculosis trials.
Service Contract Inventory data for FY2022, the most recent reported year, captures 9.4 FTEs across 19,448 contractor hours, with a derived government-paid hourly rate of $23.54/hr. The contract showed growth from FY2021 (1.5 FTEs, 3,045 hours invoiced at $39.58/hr) to FY2022, with 87 percent of contractor hours subcontracted in FY2022.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Les Centres Gheskio | $1,506,971 | |
| Les Centres Gheskio | $1,122,367 |
Quick answers
Who was awarded contract 75D30121C10170?
75D30121C10170 was awarded to Weill Medical College Of Cornell University by CDC Pittsburgh (Centers for Disease Control and Prevention) on January 1, 2021.
How much is contract 75D30121C10170 worth?
The government has obligated $3,225,561 on 75D30121C10170. Its potential value, with all options, is $5,770,310.
Was contract 75D30121C10170 competed?
The extent of competition for 75D30121C10170 was full and open competition. The government received 22 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award